The University of South Florida received $5.45 million in grants from the Bill & Melinda Gates Foundation and will work with Draper Laboratory to create advanced devices for testing malaria drugs. The first grant is to create advanced devices that mimic the human liver to better study the life cycle of the malaria parasite — particularly the elusive liver stage where the disease may be most vulnerable to attack. Malaria increasingly is growing resistant to today's therapies. "To be able to replicate and study the entire malaria infection process outside the body will be critical in developing new drugs with the potential to eliminate malaria," said Draper's Dr. Joseph Cuiffi, a principal investigator at the Draper Bioengineering Center on USF's Tampa campus. Draper will partner in the project with USF's global infectious disease research team.